Endothelial function in HIV-infected patients switching from a boosted protease inhibitor-based regimen to raltegravir: a substudy of the SPIRAL study

By Masiá Mar   Martínez Esteban   Padilla Sergio   Gatell José M.   Gutiérrez Félix  

Journal of Antimicrobial Chemotherapy, Vol. 68, Iss. 2, 2013-02 ,pp. : 409-413

Oxford University Press

Access to resources Recommend Favorite

SWIFT: Prospective 48-Week Study to Evaluate Efficacy and Safety of Switching to Emtricitabine/Tenofovir From Lamivudine/Abacavir in Virologically Suppressed HIV-1 Infected Patients on a Boosted Protease Inhibitor Containing Antiretroviral Regimen

By Campo R.   DeJesus E.   Bredeek U. F.   Henry K.   Khanlou H.   Logue K.   Brinson C.   Benson P.   Dau L.   Wang H.   White K.   Flaherty J.   Fralich T.   Guyer B.   Piontkowsky D.  

Clinical Infectious Diseases, Vol. 56, Iss. 11, 2013-06 ,pp. : 1637-1645

Oxford University Press

Access to resources Recommend Favorite

Analysis of the protease sequences of HIV-1 infected individuals after Indinavir monotherapy

By Sa-Filho D.J.   Costa L.J.   de Oliveira C.F.   Guimaraes A.P.C.   Accetturi C.V.A.   Tanuri A.   Diaz R.S.  

Journal of Clinical Virology, Vol. 28, Iss. 2, 2003-10 ,pp. : 186-202

Elsevier

Access to resources Recommend Favorite

Clinical Validation and Applicability of Different Tipranavir/Ritonavir Genotypic Scores in HIV-1 Protease Inhibitor-Experienced Patients

By  

Current HIV Research, Vol. 7, Iss. 4, 2009-07 ,pp. : 425-433

Bentham Science Publishers

Access to resources Recommend Favorite

Collinearity of protease mutations in HIV-1 samples with high-level protease inhibitor class resistance

By Babrzadeh Farbod   Varghese Vici   Pacold Mary   Liu Tommy F.   Nyrén Pål   Schiffer Celia   Fessel W. Jeffrey   Shafer Robert W.  

Journal of Antimicrobial Chemotherapy, Vol. 68, Iss. 2, 2013-02 ,pp. : 414-418

Oxford University Press

Access to resources Recommend Favorite